Blauvelt A, Papp KA, Merola JF, Gottlieb AB, Cross N, Madden C, Peterson L, Cioffi C, Griffiths CE. Bimekizumab provides rapid and sustained improvements in scalp and nail outcomes in patients with moderate to severe plaque psoriasis: 60 week results from a randomized, double blinded, Phase 2b extension study. J of Skin [Internet]. 2019Nov.9 [cited 2023Dec.1];3:S34. Available from: https://jofskin.org/index.php/skin/article/view/761